Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations
- PMID: 16267621
- DOI: 10.1007/s10554-005-9034-y
Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations
Abstract
A 27 year old female with Noonan syndrome and hypertrophic cardiomyopathy underwent cardiovascular magnetic resonance imaging. These images showed asymmetrical septal hypertrophy with maximal left ventricular end-diastolic wall thickness of 25 mm. Following administration of gadolinium, areas of hyperenhancement were seen in the anterior, anteroseptal and lateral walls. This is the first report of focal gadolinium hyperenhancement in hypertrophic cardiomyopathy due to Noonan syndrome and suggests that myocardial fibrosis can be imaged by MR hyperenhancement as seen previously in sarcomeric hypertrophic cardiomyopathy.
Similar articles
-
A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.Cardiol Young. 2008 Dec;18(6):575-80. doi: 10.1017/S104795110800320X. Epub 2008 Oct 9. Cardiol Young. 2008. PMID: 18842161
-
[Gene mutation and clinical phenotype analysis of patients with Noonan syndrome and hypertrophic cardiomyopathy].Zhonghua Er Ke Za Zhi. 2017 Oct 2;55(10):780-784. doi: 10.3760/cma.j.issn.0578-1310.2017.10.014. Zhonghua Er Ke Za Zhi. 2017. PMID: 29050118 Chinese.
-
Myocardial fragmentation associated with disruption of the Z-band in hypertrophic cardiomyopathy in Noonan syndrome.Cardiovasc Pathol. 2016 Jul-Aug;25(4):329-332. doi: 10.1016/j.carpath.2016.05.001. Epub 2016 May 5. Cardiovasc Pathol. 2016. PMID: 27216919
-
The development of familial hypertrophic cardiomyopathy: from mutation to bedside.Eur J Clin Invest. 2011 May;41(5):568-78. doi: 10.1111/j.1365-2362.2010.02439.x. Epub 2010 Dec 15. Eur J Clin Invest. 2011. PMID: 21158848 Review.
-
Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.Expert Rev Mol Diagn. 2004 Jan;4(1):99-113. doi: 10.1586/14737159.4.1.99. Expert Rev Mol Diagn. 2004. PMID: 14711353 Review.
Cited by
-
Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging.Insights Imaging. 2010 Nov;1(5-6):293-308. doi: 10.1007/s13244-010-0045-4. Epub 2010 Oct 19. Insights Imaging. 2010. PMID: 22347924 Free PMC article.
-
Cell cycle defects underlie childhood-onset cardiomyopathy associated with Noonan syndrome.iScience. 2021 Dec 9;25(1):103596. doi: 10.1016/j.isci.2021.103596. eCollection 2022 Jan 21. iScience. 2021. PMID: 34988410 Free PMC article.
-
Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.World J Cardiol. 2012 May 26;4(5):173-82. doi: 10.4330/wjc.v4.i5.173. World J Cardiol. 2012. PMID: 22655165 Free PMC article.
-
Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes.Arch Biochem Biophys. 2014 Jun 15;552-553:50-9. doi: 10.1016/j.abb.2014.01.019. Epub 2014 Jan 27. Arch Biochem Biophys. 2014. PMID: 24480308 Free PMC article.
-
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis.Nat Commun. 2018 Aug 14;9(1):3259. doi: 10.1038/s41467-018-05768-3. Nat Commun. 2018. PMID: 30108215 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources